Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
such risks were only greater with higher doses of tirzepatide than with placebo or GLP-1RA
Hypoglycemia risk increases when tirzepatide is combined with insulin or sulfonylureas, though the medication alone rarely causes low blood sugar due to its glucose-dependent mechanism
Other diagnoses and medications: Depending on what other diseases or conditions you have been diagnosed with, and what medications you are taking, your dose may need to be adjusted
Headaches and dizziness Headaches affect a meaningful percentage of users on both medications
US$ 21.35
US$ 27.16
US$ 27.66
US$ 22.46
US$ 26.66
US$ 26.51
US$ 21.41
US$ 25.08
US$ 23.86
US$ 23.87
US$ 25.56
